219 related articles for article (PubMed ID: 21055772)
21. Endotherapy for Barrett's esophagus with high-grade dysplasia and intramucosal carcinoma.
Schembre DB
J Gastrointest Surg; 2009 Jul; 13(7):1172-8. PubMed ID: 19322616
[No Abstract] [Full Text] [Related]
22. Esophageal resection for high-grade dysplasia and intramucosal carcinoma: When and how?
Konda VJ; Ferguson MK
World J Gastroenterol; 2010 Aug; 16(30):3786-92. PubMed ID: 20698041
[TBL] [Abstract][Full Text] [Related]
23. Surgical treatment of esophageal high-grade dysplasia.
Reed MF; Tolis G; Edil BH; Allan JS; Donahue DM; Gaissert HA; Moncure AC; Wain JC; Wright CD; Mathisen DJ
Ann Thorac Surg; 2005 Apr; 79(4):1110-5; discussion 1110-5. PubMed ID: 15797034
[TBL] [Abstract][Full Text] [Related]
24. Intramucosal esophageal cancer and high-grade dysplasia: which treatment frame the debate.
Oelschlager BK
J Gastrointest Surg; 2009 Jul; 13(7):1169-71. PubMed ID: 19322615
[No Abstract] [Full Text] [Related]
25. Barrett's esophagus: the role of laparoscopic fundoplication.
Abbas AE; Deschamps C; Cassivi SD; Allen MS; Nichols FC; Miller DL; Pairolero PC
Ann Thorac Surg; 2004 Feb; 77(2):393-6. PubMed ID: 14759403
[TBL] [Abstract][Full Text] [Related]
26. Clinical biology and surgical therapy of intramucosal adenocarcinoma of the esophagus.
Oh DS; Hagen JA; Chandrasoma PT; Dunst CM; Demeester SR; Alavi M; Bremner CG; Lipham J; Rizzetto C; Cote R; Demeester TR
J Am Coll Surg; 2006 Aug; 203(2):152-61. PubMed ID: 16864027
[TBL] [Abstract][Full Text] [Related]
27. [Impact of endoscopic surveillance of Barrett's esophagus on survival of patients with esophageal adenocarcinoma].
Incarbone R; Bonavina L; Bassi F; Peracchia A
Chir Ital; 2002; 54(5):591-6. PubMed ID: 12469454
[TBL] [Abstract][Full Text] [Related]
28. Photodynamic therapy (PDT) in Barrett's esophagus with dysplasia or early cancer.
Foroulis CN; Thorpe JA
Eur J Cardiothorac Surg; 2006 Jan; 29(1):30-4. PubMed ID: 16337389
[TBL] [Abstract][Full Text] [Related]
29. Endoscopic resection for Barrett's esophagus with high-grade dysplasia or early esophageal adenocarcinoma.
Watson TJ
Semin Thorac Cardiovasc Surg; 2008; 20(4):310-9. PubMed ID: 19251170
[TBL] [Abstract][Full Text] [Related]
30. Dysplasia in Barrett's esophagus: limitations of current management strategies.
Spechler SJ
Am J Gastroenterol; 2005 Apr; 100(4):927-35. PubMed ID: 15784042
[TBL] [Abstract][Full Text] [Related]
31. Muscularis mucosae duplication and the musculo-fibrous anomaly in endoscopic mucosal resections for barrett esophagus: implications for staging of adenocarcinoma.
Lewis JT; Wang KK; Abraham SC
Am J Surg Pathol; 2008 Apr; 32(4):566-71. PubMed ID: 18300796
[TBL] [Abstract][Full Text] [Related]
32. Barrett's esophagus, high-grade dysplasia, and early adenocarcinoma: a pathological study.
Cameron AJ; Carpenter HA
Am J Gastroenterol; 1997 Apr; 92(4):586-91. PubMed ID: 9128304
[TBL] [Abstract][Full Text] [Related]
33. Chronology of the Barrett's metaplasia-dysplasia-carcinoma sequence.
Theisen J; Nigro JJ; DeMeester TR; Peters JH; Gastal OL; Hagen JA; Hashemi M; Bremner CG
Dis Esophagus; 2004; 17(1):67-70. PubMed ID: 15209744
[TBL] [Abstract][Full Text] [Related]
34. Surgical management of Barrett's esophagus.
Clark GW; DeMeester TR
Ann Chir Gynaecol; 1995; 84(2):139-44. PubMed ID: 7574371
[TBL] [Abstract][Full Text] [Related]
35. Clinical impact of conventional endosonography and endoscopic ultrasound-guided fine-needle aspiration in the assessment of patients with Barrett's esophagus and high-grade dysplasia or intramucosal carcinoma who have been referred for endoscopic ablation therapy.
Shami VM; Villaverde A; Stearns L; Chi KD; Kinney TP; Rogers GB; Dye CE; Waxman I
Endoscopy; 2006 Feb; 38(2):157-61. PubMed ID: 16479423
[TBL] [Abstract][Full Text] [Related]
36. Multifocal neoplasia and nodal metastases in T1 esophageal carcinoma: implications for endoscopic treatment.
Altorki NK; Lee PC; Liss Y; Meherally D; Korst RJ; Christos P; Mazumdar M; Port JL
Ann Surg; 2008 Mar; 247(3):434-9. PubMed ID: 18376186
[TBL] [Abstract][Full Text] [Related]
37. Long-term function and quality of life after esophageal resection for cancer and Barrett's.
Deschamps C; Nichols FC; Cassivi SD; Allen MS; Pairolero PC
Surg Clin North Am; 2005 Jun; 85(3):649-56, xi. PubMed ID: 15927658
[TBL] [Abstract][Full Text] [Related]
38. [The influence of Barrett's esophagus on the clinical signs and postoperative results of GERD].
Endzinas Z; Mickevicius A; Kiudelis M
Zentralbl Chir; 2004 Apr; 129(2):99-103. PubMed ID: 15106039
[TBL] [Abstract][Full Text] [Related]
39. Poor interobserver agreement in the distinction of high-grade dysplasia and adenocarcinoma in pretreatment Barrett's esophagus biopsies.
Downs-Kelly E; Mendelin JE; Bennett AE; Castilla E; Henricks WH; Schoenfield L; Skacel M; Yerian L; Rice TW; Rybicki LA; Bronner MP; Goldblum JR
Am J Gastroenterol; 2008 Sep; 103(9):2333-40; quiz 2341. PubMed ID: 18671819
[TBL] [Abstract][Full Text] [Related]
40. Esophageal polypoid dysplasia of gastric foveolar phenotype with focal intramucosal carcinoma associated with Barrett's esophagus.
Asthana N; Mandich D; Ligato S
Am J Surg Pathol; 2008 Oct; 32(10):1581-5. PubMed ID: 18724240
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
